US2002183348A1PendingUtilityA1

Novel polyketide derivatives

Priority: Oct 1, 1999Filed: Apr 12, 2002Published: Dec 5, 2002
Est. expiryOct 1, 2019(expired)· nominal 20-yr term from priority
C07D 498/18
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to novel polyketides, host cells that produce the novel compounds, and methods fort their use. The compounds of the present invention are cyclic polyketides (also referred to as a “macrolides” or “macrolactones”) that include as part of their structure and bind to a FK binding protein wherein R 4 and R 5 are each selected from the group consisting of hydrogen, methyl, ethyl, and methoxy, provided that at least one of R 4 and R 5 is hydrogen, methyl, or ethyl. As will be explained in greater detail below, the compounds of the present invention have properties such as favorable P450 enzyme activity profiles that are desirable for use of these compounds as drugs.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A lactone having a K d  in a FKBP bunding assay of approximately equal to or less than 1 μM and including a fragment  
       
         
           
           
               
               
           
         
       
       as part of its structure wherein R 4  and R 5  are each independently selected from the group consisting of hydrogen, hydroxyl, methyl, ethyl, and methoxy, provided that at least one of R 4  and R 5  is hydrogen, methyl or ethyl.  
     
     
         2 . The lactone as in  claim 1  of the formula  
       
         
           
           
               
               
           
         
         wherein: 
 R is hydroxyl;  
 R 1  is selected from the group consisting of hydrogen, methyl, propyl, ethyl and allyl;  
 R 2  and R 3  are each independently hydrogen or hydroxyl;  
 R 4  and R 5  are each independently selected from the group consisting of hydrogen, hydroxyl, methyl,; ethyl, and methoxy, provided that at least one of R 4  and R 5  is hydrogen, methyl, or ethyl;  
 R 6  is selected from a group consisting  
                     wherein R 7  is selected from the group consisting of hydrogen, hydroxyl, methyl, ethyl, and methoxy and R 8  is selected from a group consisting of hydrogen, hydroxyl, C 1 -C 10  alkyl, C 1 -C 10  alkoxy, aryl, aryloxy, arylalkyl, and arylalkoxy; and,    a double bond exists between carbon-19 and carbon-20, or    a double bond exists between carbon-18 and carbon-19 and R and R 2  together are oxygen forming a lactone ring.    
 
       
     
     
         3 . The lactone as in  claim 1  of the formula  
       
         
           
           
               
               
           
         
       
       wherein: 
 R is hydroxyl;  
 R 1  is selected from the group consisting of hydrogen, methyl, ethyl, and allyl;  
 R 2  and R 3  are each independently hydrogen or hydroxyl;  
 R 4  and R 5  are each independently selected from the group consisting of hydrogen, hydroxyl, methyl, ethyl, and methoxy, provided that at least one of R 4  and R 5  is hydrogen, methyl, or ethyl;  
 R 7  and R 8  are each independently selected from a group consisting of hydrogen, hydroxyl, C 1 -C 10  alkyl, C 1 -C 10  alkoxy, aryl, aryloxy, arylalkyl, and arylalkoxy; and,  
 a double bond exists between carbon-19 and carbon-20, or  
 a double bond exists between carbon-18 and carbon-19 and R and R 2  together are oxygen forming a lactone ring.  
 
     
     
         4 . The lactone as in  claim 3  wherein 
 R is hydroxyl;  
 R 1  is selected from the group consisting of hydrogen, methyl, ethyl, and allyl;  
 R 2  and R 3  are each independently hydrogen or hydroxyl;  
 R 4  and R 5  are each independently selected from the group consisting of hydrogen, hydroxyl, methyl, ethyl, and methoxy, provided that at least one of R 4  and R 5  is hydrogen, methyl, or ethyl;  
 R 7  is selected from the group consisting of hydrogen, hydroxyl, methyl, ethyl, C 1 -C 5  alkoxy and aryloxy;  
 R 8  is selected from a group consisting of hydrogen, hydroxyl,  
                     wherein R 9  is selected from the group consisting of hydrogen, hydroxyl, halide, C 1 -C 5  alkyl, C 1 -C 5  hydroxyalkyl, and C 1 -C 5  alkoxy; and optionally, a double bond exists between carbon-19 and carbon-20, or a double bond exists between carbon-18 and carbon-19 and R and R 2  together are oxygen forming a lactone ring.    
 
     
     
         5 . A compound of the formula  
       
         
           
           
               
               
           
         
       
       wherein 
 R 1  is ethyl or allyl;  
 R 3  is hydrogen or hydroxyl;  
 R 4 , R 5 and R 7  are each independently selected from the group consisting of hydrogen, hydroxy, methyl, ethyl, and methoxy; and  
 R 8 is selected from a group consisting of hydrogen, hydroxyl, C 1 -C 5  alkoxy, and heteroaryloxy, provided that at least one of R 4  and R 5  is hydrogen, methyl or ethyl.  
 
     
     
         6 . The compound as in  claim 5  wherein 
 R 1  is ethyl or allyl;  
 R 3  is hydrogen or hydroxyl;  
 R 4  and R 5  are each independently selected from the group consisting of hydrogen, hydroxyl, methyl, ethyl, and methoxy,  
 R 7  is methoxy; and,  
 R 8  is hydroxyl or  
                     
 where R 9  is selected from the group consisting of hydrogen, hydroxyl, hydroxymethyl and hydroxyethyl.  
 
     
     
         7 . The compound as in  claim 6  of the formula  
       
         
           
           
               
               
           
         
       
       wherein 
 R 1  is ethyl or allyl; and  
 R 4  and R 5  are each independently selected from the group consisting of hydrogen, hydroxyl, methyl, ethyl, and methoxy.  
 
     
     
         8 . The compound as in  claim 7  wherein 
 R 1  is ethyl;  
 R 4  is methoxy; and,  
 R 5  is selected from the group consisting of hydrogen, hydroxyl, methyl, and ethyl.  
 
     
     
         9 . The compound as in  claim 7  wherein 
 R 1  is ethyl;  
 R 4  is ethyl; and,  
 R 5  is selected from the group consisting of hydrogen, hydroxyl, methyl, and ethyl.  
 
     
     
         10 . The compound as in  claim 6  of the formula  
       
         
           
           
               
               
           
         
       
       wherein 
 R 1  is ethyl or allyl; and  
 R 4 and R 5  are each independently selected from the group consisting of hydrogen, hydroxyl, methyl, ethyl, and methoxy.  
 
     
     
         11 . The compound as in  claim 6  of the formula  
       
         
           
           
               
               
           
         
       
       wherein 
 R 1  is ethyl or allyl; and  
 R 4  and R 5  are each independently selected from the group consisting of hydrogen, hydroxyl, methyl, ethyl, and methoxy.  
 
     
     
         12 . The compound as in  claim 11  wherein 
 R 1  is ethyl;  
 R 4  is methoxy; and,  
 R 5  is selected from the group consisting of hydrogen, hydroxyl, methyl, and ethyl.  
 
     
     
         13 . The compound as in  claim 11  wherein 
 R 1  is ethyl;  
 R 4  is ethyl; and,  
 R 5  is selected from the group consisting of hydrogen, hydroxyl, methyl, and ethyl.  
 
     
     
         14 . The compound as in  claim 6  of the formula  
       
         
           
           
               
               
           
         
       
     
     
         15 . The compound as in  claim 6  of the formula  
       
         
           
           
               
               
           
         
       
     
     
         16 . The compound as in  claim 6  of the formula  
       
         
           
           
               
               
           
         
       
     
     
         17 . The compound as in  claim 6  of the formula  
       
         
           
           
               
               
           
         
       
     
     
         18 . The compound as in  claim 6  of the formula  
       
         
           
           
               
               
           
         
       
     
     
         19 . The compound as in  claim 6  of the formula  
       
         
           
           
               
               
           
         
       
     
     
         20 . The compound as in  claim 6  of the formula  
       
         
           
           
               
               
           
         
       
     
     
         21 . The compound as in  claim 6  of the formula  
       
         
           
           
               
               
           
         
       
     
     
         22 . The compound as in  claim 6  of the formula  
       
         
           
           
               
               
           
         
       
     
     
         23 . The compound as in  claim 6  of the formula  
       
         
           
           
               
               
           
         
       
     
     
         24 . The compound as in  claim 6  of the formula  
       
         
           
           
               
               
           
         
       
     
     
         25 . The compound as in  claim 6  of the formula  
       
         
           
           
               
               
           
         
       
     
     
         26 . The compound as in  claim 6  of the formula  
       
         
           
           
               
               
           
         
       
     
     
         27 . The compound as in  claim 6  of the formula  
       
         
           
           
               
               
           
         
       
     
     
         28 . A recombinant host cell selected from the group consisting of KOS-45-170 (PTA-1811); KOS-60-135 (PTA-1810); KOS132-188; KOS132-191; KOS156-25; KOS156-9A; KOS156-9B; KOS156-26; KOS156-33A; KOS156-33B; and KOS156-33C.  
     
     
         29 . A compound produced by a recombinant host cell selected from the group consistingofKOS-45-170 (PTA-1811); KOS-60-135 (PTA-1810); KOS132-188; KOS132-191; KOS156-25; KOS156-9A; KOS156-9B; KOS156-26; KOS156-33A; KOS156-33B; and KOS156-33C.  
     
     
         30 . The compound of  claim 29  of the formula  
       
         
           
           
               
               
           
         
       
       produced by KOS45-170.  
     
     
         31 . The compound of  claim 29  of the formula  
       
         
           
           
               
               
           
         
       
       produced by KOS60-135.

Join the waitlist — get patent alerts

Track US2002183348A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.